UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM SD

 

SPECIALIZED DISCLOSURE REPORT

 

VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

(Exact name of the registrant as specified in its charter)

 

British Columbia, Canada   001-14956   98-0448205
(State or other jurisdiction of incorporation or organization)   (Commission File Number)   (IRS Employer Identification No.)

 

2150 St. Elzéar Blvd. West, Laval, Quebec, Canada   H7L 4A8
(Address of principal executive offices)  

(Zip code)  

 

D. Alexander Matheson   (908) 927-1164

(Name and telephone number, including area code, of the person to contact in connection with this report.)

 

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

 

X       Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2017.

 

 

Section 1 — Conflict Minerals Disclosure

 

Item 1.01 Conflict Minerals Disclosure and Report

 

Conflict Minerals Disclosure

 

The Valeant Pharmaceuticals International, Inc. Conflict Minerals Report for the calendar year ended December 31, 2017 filed herewith as Exhibit 1.01, is available at www.valeant.com

 

Item 1.02 Exhibit

 

The Conflict Minerals Report as required by Item 1.01 is filed as Exhibit 1.01 to this Form.

 

Section 2 — Exhibits

 

Item 2.01 Exhibits

 

Exhibit 1.01 Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

 

Valeant Pharmaceuticals International, Inc.
(Registrant) 		     
       
       
/s/ Christina Ackermann   Date: June 8, 2018  
By (Signature and Title)   (Date)  

       Christina Ackermann
       Executive Vice President, General Counsel

     

 

 

 

 

 

Valeant Pharma (NYSE:VRX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Valeant Pharma Charts.
Valeant Pharma (NYSE:VRX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Valeant Pharma Charts.